Yichuan Yuan - Publications

HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.

Journal: Cancer research

Published: January 20, 2026

Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial.

Journal: Med (New York, N.Y.)

Published: October 14, 2025

COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling.

Journal: Clinical and molecular hepatology

Published: September 26, 2025

USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 18, 2025

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 19, 2024

Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 19, 2024

Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.

Journal: Cancer communications (London, England)

Published: April 02, 2024

Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.

Journal: Cancer medicine

Published: October 31, 2023

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.

Journal: Cancer cell international

Published: August 09, 2023

Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.

Journal: Journal of cancer research and clinical oncology

Published: July 13, 2023

Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.

Journal: International journal of surgery (London, England)

Published: June 19, 2023

Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis.

Journal: American journal of surgery

Published: May 21, 2023